These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6195275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY, Cole LA, Kardana A.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 4. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 5. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine.
    Ayala AR, Nisula BC, Chen HC, Hodgen GD, Ross GT.
    J Clin Endocrinol Metab; 1978 Oct; 47(4):767-73. PubMed ID: 95624
    [Abstract] [Full Text] [Related]

  • 6. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 7. [Newly developed enzyme immunoassay for hCG-beta CTP and its significance in follow-up practice of trophoblastic disease].
    Sato Y, Sudo Y, Hirohashi T, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1079-86. PubMed ID: 2427625
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL, Russell HT.
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [Abstract] [Full Text] [Related]

  • 11. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 12. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
    Tomoda Y, Asai Y, Arii Y, Kaseki S, Nishi H, Miwa T, Saiki N, Ishizuka N.
    Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
    [Abstract] [Full Text] [Related]

  • 13. Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies.
    Nishimura R, Utsunomiya T, Ide K, Kitajima T, Chen HC, Strobel JL, Hussa RO, Mochizuki M.
    Jpn J Cancer Res; 1987 Aug; 78(8):833-9. PubMed ID: 3115930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T, Mochizuki M, Nishimura R.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [Abstract] [Full Text] [Related]

  • 16. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G.
    Oncodev Biol Med; 1982 Mar; 3(4):315-23. PubMed ID: 6291007
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 19. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.